Medical and pediatric oncology, not adult and pediatric oncology

Journal of Clinical Oncology

Volumn 23, Issue 18, 2005, Pages 4003-4005

  Baker, Laurence H ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; DOCETAXEL; DOXORUBICIN; GEMCITABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; VINCRISTINE;

ALVEOLAR SOFT PART SARCOMA; BONE MARROW BIOPSY; BONE RADIOGRAPHY; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CHILDHOOD CANCER; CHONDROSARCOMA; CLINICAL TRIAL; EDITORIAL; EVIDENCE BASED MEDICINE; EWING SARCOMA; HISTOPATHOLOGY; HUMAN; MEDICAL EXPERT; MEDICAL SOCIETY; NONRHABDOMYOSARCOMA SOFT TISSUE SARCOMA; ONCOLOGY; OSTEOSARCOMA; PRIORITY JOURNAL; RHABDOMYOSARCOMA; SOFT TISSUE SARCOMA; ADULT; CHILD; NOTE; PEDIATRICS; SARCOMA; SOFT TISSUE TUMOR;

ADULT; CHILD; CLINICAL TRIALS; HUMANS; MEDICAL ONCOLOGY; PEDIATRICS; SARCOMA; SOFT TISSUE NEOPLASMS;

EID: 23044461475     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.11.952     Document Type: Editorial

References (23)

1. Jemal A, Tiwari RC, Murray T, et al: Cancer statistics, 2004. CA Cancer J Clin 54:8-29, 2004
2. Gloeckler Reis LA, Smith MA, Gurney JG, et al: Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975-1995. Bethesda, MD, National Cancer Institute, SEER program publication 99-4649, 1999
3. Paulussen M, Ahrens S, Dunst J, et al: Localized Ewing tumor of bone: Final results of the cooperative Ewing's Sarcoma Study CESS 86. J Clin Oncol 19:1818-1829, 2001
4. Nesbit ME Jr, Gehan EA, Burgert EO Jr, et al: Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: A long-term follow-up of the First Intergroup study. J Clin Oncol 8:1664-1674, 1990
5. Grier HE, Krailo MD, Tarbell NJ, et al: Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 348:694-701, 2003
6. Ginsberg JP, Woo SY, Hicks MJ, et al: Ewing's sarcoma family of tumors: Ewing's sarcoma of bone and soft tissue and the peripheral primitive neuroectodermal tumors, in Pizzo PA, Poplack DG (eds): Principles and Practice of Pediatric Oncology (ed 4). Philadelphia, PA, Lippincott Williams & Wilkins, 2002, 973-1016
7. Link MP, Gebhardt MC, Meyers PA: Osteosarcoma, in Pizzo PA, Poplack DG (eds): Principles and Practice of Pediatric Oncology (ed 4). Philadelphia, PA, Lippincott, Williams & Wilkins, 2002, p 1051
8. Meyers PA, Gorlick R: Osteosarcoma. Pediatr Clin North Am 44:973-989, 1997
9. Link MP, Goorin AM, Horowitz M, et al: Adjuvant chemotherapy of high-grade osteosarcoma of the extremity: Updated results of the Multi-Institutional Osteosarcoma Study. Clin Orthop 270:8-14, 1991
10. Dagher R, Helman L: Rhabdomyosarcoma: An overview. Oncologist 4:34-44, 1999
11. Maurer HM, Beltangady M, Gehan EA, et al: The Intergroup Rhabdomyosarcoma Study: I. A final report. Cancer 61:209-220, 1988
12. Crist W, Gehan EA, Ragab AH, et al: The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 13:610-630, 1995
13. Raney RB, Anderson JR, Barr FG, et al: Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: A selective review of Intergroup Rhabdomyosarcoma Study Group experience and rationale for Intergroup Rhabdomyosarcoma Study V. J Pediatr Hematol Oncol 23:215-220, 2001
14. Spunt SL, Poquette CA, Hurt YS, et al: Prognostic factors for children and adolescents with surgically resected non-rhabdomyosarcoma soft tissue sarcoma: An analysis of 121 patients treated at St. Jude Children's Research Hospital. J Clin Oncol 17:3697-3705, 1999
15. Pratt CB, Pappo AS, Gieser P, et al: Role of adjuvant chemotherapy in the treatment of surgically resected non-rhabdomyosarcomatous soft tissue sarcomas: A Pediatric Oncology Group study. J Clin Oncol 17:1219-1226, 1999
16. Pappo AS, Rao BN, Jenkins JJ, et al: Metastatic nonrhabdomyosarcomatous soft tissue sarcomas in children and adolescents: The St. Jude Children's Research Hospital experience. Med Pediatr Oncol 33:76-82, 1999
17. Pappo AS, Devidas M, Jenkins J, et al: Phase II trial of neoadjuvant vincristine, ifosfamide, and doxorubicin with granulocyte colony-stimulating factor support in children and adolescents with advanced-stage nonrhabdomyosarcomatous soft tissue sarcomas: A Pediatric Oncology Group study. J Clin Oncol 23:4031-4038, 2005
18. Ferrari A, Casanova M, Collini P, et al: Adult-type soft tissue sarcomas in pediatric age: Experience at the Istituto Nazionale Tumori in Milan. J Clin Oncol 23:4039-4047, 2005
19. Staudenherz A, Steiner B, Puig S, et al: Is there a diagnostic role for bone scanning of patients with a high pretest probability for metastatic renal cell carcinoma? Cancer 85:153-155, 1999
20. Brown DH, Leakos M: The value of a routine bone scan in a metastatic survey. J Otolaryngol 27:187-189, 1998
21. Antman KA, Crowley J, Balcerzak SP, et al: An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcoma. J Clin Oncol 11:1276-1285, 1993
22. Schutte J, Mourisden HT, Steward W, et al: Ifosfamide plus doxorubicin in previously untreated patients with advanced soft tissue sarcoma. Cancer Chemother Pharmacol 31:S204-S209, 1993 (suppl 2)
23. Van Glabbeke M, van Oosterom AT, Oosterhuis JW, et al: Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: An analysis of 2185 patients treated with anthracycline-containing first-line regimens-A European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study. J Clin Oncol 17:150-157, 1999